These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1856144)

  • 1. Once daily dosing of aminoglycoside: one step forward.
    Pechère JC; Craig WA; Meunier F
    J Antimicrob Chemother; 1991 May; 27 Suppl C():149-52. PubMed ID: 1856144
    [No Abstract]   [Full Text] [Related]  

  • 2. Single daily dose amikacin in paediatric patients with severe gram-negative infections.
    Trujillo H; Robledo J; Robledo C; Espinal D; Garces G; Mejia J; Restrepo C; Restrepo F; Mejia de Rodriguez GI; Tamayo de Guitierrez MC
    J Antimicrob Chemother; 1991 May; 27 Suppl C():141-7. PubMed ID: 1856143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe gram-negative infections.
    Kafetzis DA; Sianidou L; Vlachos E; Davros J; Baïramis T; Papandreou Y; Paraskaki E; Scouroliakou M; Hadzis A; Papadatos J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():105-12. PubMed ID: 1906861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
    Maller R; Ahrne H; Eilard T; Eriksson I; Lausen I
    J Antimicrob Chemother; 1991 May; 27 Suppl C():121-8. PubMed ID: 1856141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
    Beaucaire G; Leroy O; Beuscart C; Karp P; Chidiac C; Caillaux M
    J Antimicrob Chemother; 1991 May; 27 Suppl C():91-103. PubMed ID: 1856149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
    Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily amikacin. Report of a meeting.
    J Antimicrob Chemother; 1991 May; 27 Suppl C():1-152. PubMed ID: 1856139
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility.
    Yoshida M; Morita R; Lefor AT; Nabeshima T
    Int J Antimicrob Agents; 2007 Jan; 29(1):113-6. PubMed ID: 17137756
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
    Falagas ME; Karageorgopoulos DE; Georgantzi GG; Sun C; Wang R; Rafailidis PI
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):207-18. PubMed ID: 22339194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The combination therapy of amikacin and beta-lactam antibiotic in the severe bacterial infections (author's transl)].
    Takigami T
    Jpn J Antibiot; 1982 Feb; 35(2):369-74. PubMed ID: 7087174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation.
    Viscoli C; Dudley M; Ferrea G; Boni L; Castagnola E; Barretta MA; Lanino E; Loy A; Moroni C; Somenzi M
    J Antimicrob Chemother; 1991 May; 27 Suppl C():113-20. PubMed ID: 1856140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections.
    Paradisi F; Corti G
    J Chemother; 1995 Aug; 7(4):338-43. PubMed ID: 8568544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amoxycillin/clavulanic acid--beginning of new era in antibiotic therapy of bacterial infections].
    Iarkin MV
    Antibiot Khimioter; 1998; 43(5):47-8. PubMed ID: 9644525
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
    Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.